0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Enzyme Replacement Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-1Z13101
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Enzyme Replacement Therapy Sales Market Report 2023
BUY CHAPTERS

Enzyme Replacement Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1Z13101
Report
March 2024
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Enzyme Replacement Therapy - Market Size

The global market for Enzyme Replacement Therapy was estimated to be worth US$ 11830 million in 2023 and is forecast to a readjusted size of US$ 29910 million by 2030 with a CAGR of 14.0% during the forecast period 2024-2030

Enzyme Replacement Therapy - Market

Enzyme Replacement Therapy - Market

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.
In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enzyme Replacement Therapy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Enzyme Replacement Therapy by region & country, by Type, and by Application.
The Enzyme Replacement Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme Replacement Therapy.
Market Segmentation

Scope of Enzyme Replacement Therapy - Market Report

Report Metric Details
Report Name Enzyme Replacement Therapy - Market
Forecasted market size in 2030 US$ 29910 million
CAGR 14.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Injectable Agents
  • Oral Agents
Segment by Application
  • Gaucher Disease
  • Fabry Disease
  • MPS Disease
  • Gastrointestinal Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Enzyme Replacement Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Enzyme Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Enzyme Replacement Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Enzyme Replacement Therapy - Market size in 2030?

Ans: The Enzyme Replacement Therapy - Market size in 2030 will be US$ 29910 million.

What is the market share of major companies in Enzyme Replacement Therapy - Market?

Ans: Global top three manufacturers hold a share about 95%.

What is the Enzyme Replacement Therapy - Market share by type?

Ans: In terms of product, Oral Agents is the largest segment, with a share nearly 95%.

Who are the main players in the Enzyme Replacement Therapy - Market report?

Ans: The main players in the Enzyme Replacement Therapy - Market are Sanofi, Takeda, BioMarin, AbbVie, Alexion, Allergan, Horizon Pharma, Johnson & Johnson, Actelion, Recordati Rare Diseases, Pfizer, Digestive Care, Leadiant Biosciences

What are the Application segmentation covered in the Enzyme Replacement Therapy - Market report?

Ans: The Applications covered in the Enzyme Replacement Therapy - Market report are Gaucher Disease, Fabry Disease, MPS Disease, Gastrointestinal Disease, Others

What are the Type segmentation covered in the Enzyme Replacement Therapy - Market report?

Ans: The Types covered in the Enzyme Replacement Therapy - Market report are Injectable Agents, Oral Agents

1 Market Overview
1.1 Enzyme Replacement Therapy Product Introduction
1.2 Global Enzyme Replacement Therapy Market Size Forecast
1.2.1 Global Enzyme Replacement Therapy Sales Value (2019-2030)
1.2.2 Global Enzyme Replacement Therapy Sales Volume (2019-2030)
1.2.3 Global Enzyme Replacement Therapy Sales Price (2019-2030)
1.3 Enzyme Replacement Therapy Market Trends & Drivers
1.3.1 Enzyme Replacement Therapy Industry Trends
1.3.2 Enzyme Replacement Therapy Market Drivers & Opportunity
1.3.3 Enzyme Replacement Therapy Market Challenges
1.3.4 Enzyme Replacement Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Enzyme Replacement Therapy Players Revenue Ranking (2023)
2.2 Global Enzyme Replacement Therapy Revenue by Company (2019-2024)
2.3 Global Enzyme Replacement Therapy Players Sales Volume Ranking (2023)
2.4 Global Enzyme Replacement Therapy Sales Volume by Company Players (2019-2024)
2.5 Global Enzyme Replacement Therapy Average Price by Company (2019-2024)
2.6 Key Manufacturers Enzyme Replacement Therapy Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Enzyme Replacement Therapy Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Enzyme Replacement Therapy
2.9 Enzyme Replacement Therapy Market Competitive Analysis
2.9.1 Enzyme Replacement Therapy Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Enzyme Replacement Therapy Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Replacement Therapy as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Injectable Agents
3.1.2 Oral Agents
3.2 Global Enzyme Replacement Therapy Sales Value by Type
3.2.1 Global Enzyme Replacement Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Enzyme Replacement Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Enzyme Replacement Therapy Sales Value, by Type (%) (2019-2030)
3.3 Global Enzyme Replacement Therapy Sales Volume by Type
3.3.1 Global Enzyme Replacement Therapy Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Enzyme Replacement Therapy Sales Volume, by Type (2019-2030)
3.3.3 Global Enzyme Replacement Therapy Sales Volume, by Type (%) (2019-2030)
3.4 Global Enzyme Replacement Therapy Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Gaucher Disease
4.1.2 Fabry Disease
4.1.3 MPS Disease
4.1.4 Gastrointestinal Disease
4.1.5 Others
4.2 Global Enzyme Replacement Therapy Sales Value by Application
4.2.1 Global Enzyme Replacement Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Enzyme Replacement Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Enzyme Replacement Therapy Sales Value, by Application (%) (2019-2030)
4.3 Global Enzyme Replacement Therapy Sales Volume by Application
4.3.1 Global Enzyme Replacement Therapy Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Enzyme Replacement Therapy Sales Volume, by Application (2019-2030)
4.3.3 Global Enzyme Replacement Therapy Sales Volume, by Application (%) (2019-2030)
4.4 Global Enzyme Replacement Therapy Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Enzyme Replacement Therapy Sales Value by Region
5.1.1 Global Enzyme Replacement Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Enzyme Replacement Therapy Sales Value by Region (2019-2024)
5.1.3 Global Enzyme Replacement Therapy Sales Value by Region (2025-2030)
5.1.4 Global Enzyme Replacement Therapy Sales Value by Region (%), (2019-2030)
5.2 Global Enzyme Replacement Therapy Sales Volume by Region
5.2.1 Global Enzyme Replacement Therapy Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Enzyme Replacement Therapy Sales Volume by Region (2019-2024)
5.2.3 Global Enzyme Replacement Therapy Sales Volume by Region (2025-2030)
5.2.4 Global Enzyme Replacement Therapy Sales Volume by Region (%), (2019-2030)
5.3 Global Enzyme Replacement Therapy Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Enzyme Replacement Therapy Sales Value, 2019-2030
5.4.2 North America Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Enzyme Replacement Therapy Sales Value, 2019-2030
5.5.2 Europe Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Enzyme Replacement Therapy Sales Value, 2019-2030
5.6.2 Asia Pacific Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Enzyme Replacement Therapy Sales Value, 2019-2030
5.7.2 South America Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Enzyme Replacement Therapy Sales Value, 2019-2030
5.8.2 Middle East & Africa Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Enzyme Replacement Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Enzyme Replacement Therapy Sales Value
6.2.1 Key Countries/Regions Enzyme Replacement Therapy Sales Value, 2019-2030
6.2.2 Key Countries/Regions Enzyme Replacement Therapy Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Enzyme Replacement Therapy Sales Value, 2019-2030
6.3.2 United States Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Enzyme Replacement Therapy Sales Value, 2019-2030
6.4.2 Europe Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Enzyme Replacement Therapy Sales Value, 2019-2030
6.5.2 China Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Enzyme Replacement Therapy Sales Value, 2019-2030
6.6.2 Japan Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Enzyme Replacement Therapy Sales Value, 2019-2030
6.7.2 South Korea Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Enzyme Replacement Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Enzyme Replacement Therapy Sales Value, 2019-2030
6.9.2 India Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Enzyme Replacement Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Sanofi
7.1.1 Sanofi Company Information
7.1.2 Sanofi Introduction and Business Overview
7.1.3 Sanofi Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Sanofi Enzyme Replacement Therapy Product Offerings
7.1.5 Sanofi Recent Development
7.2 Takeda
7.2.1 Takeda Company Information
7.2.2 Takeda Introduction and Business Overview
7.2.3 Takeda Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Takeda Enzyme Replacement Therapy Product Offerings
7.2.5 Takeda Recent Development
7.3 BioMarin
7.3.1 BioMarin Company Information
7.3.2 BioMarin Introduction and Business Overview
7.3.3 BioMarin Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.3.4 BioMarin Enzyme Replacement Therapy Product Offerings
7.3.5 BioMarin Recent Development
7.4 AbbVie
7.4.1 AbbVie Company Information
7.4.2 AbbVie Introduction and Business Overview
7.4.3 AbbVie Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.4.4 AbbVie Enzyme Replacement Therapy Product Offerings
7.4.5 AbbVie Recent Development
7.5 Alexion
7.5.1 Alexion Company Information
7.5.2 Alexion Introduction and Business Overview
7.5.3 Alexion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Alexion Enzyme Replacement Therapy Product Offerings
7.5.5 Alexion Recent Development
7.6 Allergan
7.6.1 Allergan Company Information
7.6.2 Allergan Introduction and Business Overview
7.6.3 Allergan Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Allergan Enzyme Replacement Therapy Product Offerings
7.6.5 Allergan Recent Development
7.7 Horizon Pharma
7.7.1 Horizon Pharma Company Information
7.7.2 Horizon Pharma Introduction and Business Overview
7.7.3 Horizon Pharma Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Horizon Pharma Enzyme Replacement Therapy Product Offerings
7.7.5 Horizon Pharma Recent Development
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Information
7.8.2 Johnson & Johnson Introduction and Business Overview
7.8.3 Johnson & Johnson Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Johnson & Johnson Enzyme Replacement Therapy Product Offerings
7.8.5 Johnson & Johnson Recent Development
7.9 Actelion
7.9.1 Actelion Company Information
7.9.2 Actelion Introduction and Business Overview
7.9.3 Actelion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Actelion Enzyme Replacement Therapy Product Offerings
7.9.5 Actelion Recent Development
7.10 Recordati Rare Diseases
7.10.1 Recordati Rare Diseases Company Information
7.10.2 Recordati Rare Diseases Introduction and Business Overview
7.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Recordati Rare Diseases Enzyme Replacement Therapy Product Offerings
7.10.5 Recordati Rare Diseases Recent Development
7.11 Pfizer
7.11.1 Pfizer Company Information
7.11.2 Pfizer Introduction and Business Overview
7.11.3 Pfizer Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Pfizer Enzyme Replacement Therapy Product Offerings
7.11.5 Pfizer Recent Development
7.12 Digestive Care
7.12.1 Digestive Care Company Information
7.12.2 Digestive Care Introduction and Business Overview
7.12.3 Digestive Care Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Digestive Care Enzyme Replacement Therapy Product Offerings
7.12.5 Digestive Care Recent Development
7.13 Leadiant Biosciences
7.13.1 Leadiant Biosciences Company Information
7.13.2 Leadiant Biosciences Introduction and Business Overview
7.13.3 Leadiant Biosciences Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Leadiant Biosciences Enzyme Replacement Therapy Product Offerings
7.13.5 Leadiant Biosciences Recent Development
8 Industry Chain Analysis
8.1 Enzyme Replacement Therapy Industrial Chain
8.2 Enzyme Replacement Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Enzyme Replacement Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Enzyme Replacement Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Enzyme Replacement Therapy Market Trends
    Table 2. Enzyme Replacement Therapy Market Drivers & Opportunity
    Table 3. Enzyme Replacement Therapy Market Challenges
    Table 4. Enzyme Replacement Therapy Market Restraints
    Table 5. Global Enzyme Replacement Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Enzyme Replacement Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Global Enzyme Replacement Therapy Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Enzyme Replacement Therapy Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Enzyme Replacement Therapy Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Enzyme Replacement Therapy Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Enzyme Replacement Therapy Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Enzyme Replacement Therapy
    Table 13. Global Enzyme Replacement Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enzyme Replacement Therapy as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Enzyme Replacement Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Enzyme Replacement Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Enzyme Replacement Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Enzyme Replacement Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Enzyme Replacement Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Enzyme Replacement Therapy Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Enzyme Replacement Therapy Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Enzyme Replacement Therapy Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Enzyme Replacement Therapy Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Enzyme Replacement Therapy Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Enzyme Replacement Therapy Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Enzyme Replacement Therapy Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Enzyme Replacement Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Enzyme Replacement Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Enzyme Replacement Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Enzyme Replacement Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Enzyme Replacement Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Enzyme Replacement Therapy Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Enzyme Replacement Therapy Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Enzyme Replacement Therapy Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Enzyme Replacement Therapy Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Enzyme Replacement Therapy Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Enzyme Replacement Therapy Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Enzyme Replacement Therapy Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Enzyme Replacement Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Enzyme Replacement Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Enzyme Replacement Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Enzyme Replacement Therapy Sales Value by Region (2019-2024) & (%)
    Table 44. Global Enzyme Replacement Therapy Sales Value by Region (2025-2030) & (%)
    Table 45. Global Enzyme Replacement Therapy Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Enzyme Replacement Therapy Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Enzyme Replacement Therapy Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Enzyme Replacement Therapy Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Enzyme Replacement Therapy Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Enzyme Replacement Therapy Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Enzyme Replacement Therapy Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Enzyme Replacement Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Enzyme Replacement Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Enzyme Replacement Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Enzyme Replacement Therapy Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Enzyme Replacement Therapy Sales Volume, (2025-2030) & (K Units)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Sanofi Enzyme Replacement Therapy Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. Takeda Company Information
    Table 63. Takeda Introduction and Business Overview
    Table 64. Takeda Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Takeda Enzyme Replacement Therapy Product Offerings
    Table 66. Takeda Recent Development
    Table 67. BioMarin Company Information
    Table 68. BioMarin Introduction and Business Overview
    Table 69. BioMarin Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. BioMarin Enzyme Replacement Therapy Product Offerings
    Table 71. BioMarin Recent Development
    Table 72. AbbVie Company Information
    Table 73. AbbVie Introduction and Business Overview
    Table 74. AbbVie Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. AbbVie Enzyme Replacement Therapy Product Offerings
    Table 76. AbbVie Recent Development
    Table 77. Alexion Company Information
    Table 78. Alexion Introduction and Business Overview
    Table 79. Alexion Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Alexion Enzyme Replacement Therapy Product Offerings
    Table 81. Alexion Recent Development
    Table 82. Allergan Company Information
    Table 83. Allergan Introduction and Business Overview
    Table 84. Allergan Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Allergan Enzyme Replacement Therapy Product Offerings
    Table 86. Allergan Recent Development
    Table 87. Horizon Pharma Company Information
    Table 88. Horizon Pharma Introduction and Business Overview
    Table 89. Horizon Pharma Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Horizon Pharma Enzyme Replacement Therapy Product Offerings
    Table 91. Horizon Pharma Recent Development
    Table 92. Johnson & Johnson Company Information
    Table 93. Johnson & Johnson Introduction and Business Overview
    Table 94. Johnson & Johnson Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Johnson & Johnson Enzyme Replacement Therapy Product Offerings
    Table 96. Johnson & Johnson Recent Development
    Table 97. Actelion Company Information
    Table 98. Actelion Introduction and Business Overview
    Table 99. Actelion Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Actelion Enzyme Replacement Therapy Product Offerings
    Table 101. Actelion Recent Development
    Table 102. Recordati Rare Diseases Company Information
    Table 103. Recordati Rare Diseases Introduction and Business Overview
    Table 104. Recordati Rare Diseases Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Recordati Rare Diseases Enzyme Replacement Therapy Product Offerings
    Table 106. Recordati Rare Diseases Recent Development
    Table 107. Pfizer Company Information
    Table 108. Pfizer Introduction and Business Overview
    Table 109. Pfizer Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. Pfizer Enzyme Replacement Therapy Product Offerings
    Table 111. Pfizer Recent Development
    Table 112. Digestive Care Company Information
    Table 113. Digestive Care Introduction and Business Overview
    Table 114. Digestive Care Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Digestive Care Enzyme Replacement Therapy Product Offerings
    Table 116. Digestive Care Recent Development
    Table 117. Leadiant Biosciences Company Information
    Table 118. Leadiant Biosciences Introduction and Business Overview
    Table 119. Leadiant Biosciences Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 120. Leadiant Biosciences Enzyme Replacement Therapy Product Offerings
    Table 121. Leadiant Biosciences Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Enzyme Replacement Therapy Downstream Customers
    Table 125. Enzyme Replacement Therapy Distributors List
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Enzyme Replacement Therapy Product Picture
    Figure 2. Global Enzyme Replacement Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Enzyme Replacement Therapy Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Enzyme Replacement Therapy Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Enzyme Replacement Therapy Report Years Considered
    Figure 7. Global Enzyme Replacement Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Enzyme Replacement Therapy Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enzyme Replacement Therapy Revenue in 2023
    Figure 10. Enzyme Replacement Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Injectable Agents Picture
    Figure 12. Oral Agents Picture
    Figure 13. Global Enzyme Replacement Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Enzyme Replacement Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Enzyme Replacement Therapy Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Enzyme Replacement Therapy Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Enzyme Replacement Therapy Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Gaucher Disease
    Figure 19. Product Picture of Fabry Disease
    Figure 20. Product Picture of MPS Disease
    Figure 21. Product Picture of Gastrointestinal Disease
    Figure 22. Product Picture of Others
    Figure 23. Global Enzyme Replacement Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Enzyme Replacement Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Enzyme Replacement Therapy Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 26. Global Enzyme Replacement Therapy Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Enzyme Replacement Therapy Price by Application (2019-2030) & (USD/Unit)
    Figure 28. North America Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Enzyme Replacement Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Enzyme Replacement Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Enzyme Replacement Therapy Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Enzyme Replacement Therapy Sales Volume (%), (2019-2030)
    Figure 40. United States Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Enzyme Replacement Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Enzyme Replacement Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Enzyme Replacement Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 61. Enzyme Replacement Therapy Industrial Chain
    Figure 62. Enzyme Replacement Therapy Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Aspiration Biopsy Needles Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18Q7536
Mon May 06 00:00:00 UTC 2024

Add to Cart

Global Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22K11387
Mon May 06 00:00:00 UTC 2024

Add to Cart

Global Arthroscopy Razor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14I11600
Mon May 06 00:00:00 UTC 2024

Add to Cart

Global Lung Biopsy Needle Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17U11690
Mon May 06 00:00:00 UTC 2024

Add to Cart